Dietary interventions can improve clinical outcomes for some women with breast cancer
the ONA take:
Data from the Women’s Intervention Nutrition Study (WINS) presented at the San Antonio Breast Cancer Symposium demonstrated that reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
The WINS was a randomized trial, to which 2,437 women ages 48 to 79 years were recruited. The women had early stage hormone-unrelated breast cancer, receiving standard-of-care treatments at 39 centers in the United States. They were randomly assigned to follow a dietary intervention that reduced their fat intake for 5 years following diagnosis (975 patients) or to a control group (1,462 patients).
Centrally trained, registered dietitians implemented the low-fat eating plan via eight biweekly individual counseling sessions and subsequent contacts every 3 weeks, plus unannounced 24-hour telephone recalls performed annually. In addition, the women self-monitored and recorded their fat intake in a book. After more than 15 years of follow-up, death rates from all causes in the intervention group were significantly lower than in the control group.
“The dietary intervention was supported for a median of 5 years,” the researchers reported. Based on their findings, however, the researchers suggest that for lifestyle interventions to have a long-term influence on clinical outcomes, they must be lifelong changes rather than short-term interventions.
Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
- FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy
- Efficacy of Octreotide LAR, Lanreotide in Management of Carcinoid Tumors
- Multivitamin Use May Reduce Risk of Chemo-Induced Neuropathy
- Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination
- Adjuvant Durvalumab Therapy May Prolong Progression-free Survival in NSCLC
- Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer
- Cannabis Reduces Response Rate to Immunotherapy for Cancer
- Perioperative Blockade of Pathways May Improve Outcomes in Breast Cancer
- Zika Virus Preferentially Targets Glioblastoma Stem Cells
- Daratumumab Infusion-Related Reactions Managed by Pre/Postinfusion Medications
- Lorazepam Plus Haloperidol Improves Agitation in Cancer-Related Delirium
- Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
- Treating Intractable Hiccups in Advanced Cancer, Palliative Care Setting
- Severe Mental Illness May Worsen Breast Cancer Survival Outcomes
- Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|